Product Code: GVR-4-68040-302-2
Nanorobots In Healthcare Market Growth & Trends:
The global nanorobots in healthcare market size is expected to reach USD 10.64 billion by 2030, registering a CAGR of 6.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing development of technologically advanced products is anticipated to boost market growth. In January 2020, Researchers at King Abdullah University of Science and Technology (KAUST) developed nanorobots, consisting of drug-coated iron nanowires. These nanorobots can be directed to a tumor site using an external magnetic field. Once in place, they initiate a three-step cancer-killing process, potentially offering a promising option for cancer treatment. Upon reaching cancer cells, the nanowires release their drug payload, puncture the cell membrane, and administer a burst of heat.
Growing cases of root canal treatment across the globe are fostering the demand for nanorobots in healthcare. For instance, the American Association of Endodontists (AAE) reports that 25 million root canal procedures are performed every year. Each day, an average of 41,000 root canals are carried out. Market players are continually researching the precise treatment of root canals. For instance, in May 2022, Theranautilus, a startup that was developed at the Indian Institute of Science (IISc), demonstrated in a study that using a magnetic field to manipulate nano-sized robots can assist in removing bacteria deep within dentinal tubules, thereby enhancing the efficacy of root canal treatment.
The major players operating in the market are adopting strategies, such as collaborations, supply agreements, and partnerships, with a major focus on enhancing product formation and reach. In addition, market players are securing funding from government and non-government bodies to develop advanced treatment. For instance, in April 2023, Nanovery, a manufacturer of a nanorobot platform capable of detecting chronic illnesses, such as liver diseases, prostate cancer, and severe conditions like acute kidney and liver toxicity, secured over USD 2.35 million for a cancer diagnostic solution.
Moreover, growing prevalence of cancer across the globe is boosting the demand for nanobots. For instance, according to the WHO report, there is a projected 77% increase in new cancer cases by 2050, with over 35 million cases, up from an estimated 20 million cases in 2020. Furthermore, increasing government funding in nanotechnology is fostering the market growth. For instance, the National Nanotechnology Initiative (NNI) leads nanotechnology research in the U.S. with a budget of USD 1.99 billion for 2023. NNI's areas of focus encompass nanoscience, device advancement, and tackling global issues like COVID-19. Such increasing investment in nanotechnology will escalate market growth.
Nanorobots In Healthcare Market Report Highlights:
- Based on type, the nanomanipulator segment held the largest revenue share in 2023 owing to the increased demand for electron microscopes and continuous technological advancements
- Based on application, the targeted drug delivery segment is anticipated to grow at the fastest growth rate over the forecast period owing to the rising cases of cancer
- North America dominated the global market in 2023 due to the high level of private and public funding coupled with the presence of key market players
- Furthermore, increasing cancer cases in the region will supplement the overall market growth
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Segment scope
- 1.1.2. Regional scope
- 1.1.3. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.7. Research Assumptions
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Application outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Nanorobots in Healthcare Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.3. Nanorobots in Healthcare: Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTLE Analysis
- 3.4. Regulatory Framework
Chapter 4. Nanorobots in Healthcare Market Segment Analysis, By Type, 2018 - 2030 (USD Million)
- 4.1. Definition and Scope
- 4.2. Type Market Share Analysis, 2023 & 2030
- 4.3. Segment Dashboard
- 4.4. Global Nanorobots in Healthcare Market, by Type, 2018 to 2030
- 4.5. Nanomanipulator
- 4.5.1. Nanomanipulator market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.2. Electron microscope
- 4.5.2.1. Electron microscope market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.3. Scanning probe microscope
- 4.5.3.1. Scanning probe microscope market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.6. Bio-nanorobotics
- 4.6.1. Bio-nanorobotics market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.7. Magnetically guided nanorobots
- 4.7.1. Magnetically guided nanorobots market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Nanorobots in Healthcare Market Segment Analysis, By Application, 2018 - 2030 (USD Million)
- 5.1. Definition and Scope
- 5.2. Application Market Share Analysis, 2023 & 2030
- 5.3. Segment Dashboard
- 5.4. Global Nanorobots in Healthcare Market, by Application, 2018 to 2030
- 5.5. Targeted drug delivery
- 5.5.1. Targeted drug delivery market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.6. Medical imaging
- 5.6.1. Medical imaging market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.7. Surgical
- 5.7.1. Surgical market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.8. Dental
- 5.8.1. Dental market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.9. Others
- 5.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Nanorobots in Healthcare Market Segment Analysis, By Region, By Type, By Application, 2018- 2030 (USD Million)
- 6.1. Regional Market Share Analysis, 2023 & 2030
- 6.2. Regional Market Dashboard
- 6.3. Regional Market Snapshot
- 6.4. Nanorobots in Healthcare Market Share by Region, 2023 & 2030:
- 6.5. North America
- 6.5.1. North America nanorobots in healthcare market, 2018 - 2030 (USD Million)
- 6.5.2. U.S.
- 6.5.2.1. U.S. nanorobots in healthcare market, 2018 - 2030 (USD Million)
- 6.5.3. Canada
- 6.5.3.1. Canada nanorobots in healthcare market, 2018 - 2030 (USD Million)
- 6.5.4. Mexico
- 6.5.4.1. Mexico nanorobots in healthcare market, 2018 - 2030 (USD Million)
- 6.6. Europe
- 6.6.1. Europe nanorobots in healthcare market, 2018 - 2030 (USD Million)
- 6.6.2. UK
- 6.6.2.1. UK nanorobots in healthcare market, 2018 - 2030 (USD Million)
- 6.6.3. Germany
- 6.6.3.1. Germany nanorobots in healthcare market, 2018 - 2030 (USD Million)
- 6.6.4. France
- 6.6.4.1. France nanorobots in healthcare market, 2018 - 2030 (USD Million)
- 6.6.5. Italy
- 6.6.5.1. Italy nanorobots in healthcare market, 2018 - 2030 (USD Million)
- 6.6.6. Spain
- 6.6.6.1. Spain nanorobots in healthcare market, 2018 - 2030 (USD Million)
- 6.6.7. Norway
- 6.6.7.1. Norway nanorobots in healthcare market, 2018 - 2030 (USD Million)
- 6.6.8. Sweden
- 6.6.8.1. Sweden nanorobots in healthcare market, 2018 - 2030 (USD Million)
- 6.6.9. Denmark
- 6.6.9.1. Denmark nanorobots in healthcare market, 2018 - 2030 (USD Million)
- 6.7. Asia Pacific
- 6.7.1. Japan
- 6.7.1.1. Japan nanorobots in healthcare market, 2018 - 2030 (USD Million)
- 6.7.2. China
- 6.7.2.1. China nanorobots in healthcare market, 2018 - 2030 (USD Million)
- 6.7.3. India
- 6.7.3.1. India nanorobots in healthcare market, 2018 - 2030 (USD Million)
- 6.7.4. Australia
- 6.7.4.1. Australia nanorobots in healthcare market, 2018 - 2030 (USD Million)
- 6.7.5. South Korea
- 6.7.5.1. South Korea nanorobots in healthcare market, 2018 - 2030 (USD Million)
- 6.7.6. Thailand
- 6.7.6.1. Thailand nanorobots in healthcare market, 2018 - 2030 (USD Million)
- 6.8. Latin America
- 6.8.1. Brazil
- 6.8.1.1. Brazil nanorobots in healthcare market, 2018 - 2030 (USD Million)
- 6.8.2. Argentina
- 6.8.2.1. Argentina nanorobots in healthcare market, 2018 - 2030 (USD Million)
- 6.9. MEA
- 6.9.1. South Africa
- 6.9.1.1. South Africa nanorobots in healthcare market, 2018 - 2030 (USD Million)
- 6.9.2. Saudi Arabia
- 6.9.2.1. Saudi Arabia nanorobots in healthcare market, 2018 - 2030 (USD Million)
- 6.9.3. UAE
- 6.9.3.1. UAE nanorobots in healthcare market, 2018 - 2030 (USD Million)
- 6.9.4. Kuwait
- 6.9.4.1. Kuwait nanorobots in healthcare market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company Categorization
- 7.3. Company Profiles
- 7.3.1. Bruker
- 7.3.1.1. Company overview
- 7.3.1.2. Financial performance
- 7.3.1.3. Product benchmarking
- 7.3.1.4. Strategic initiatives
- 7.3.2. Ginkgo Bioworks
- 7.3.2.1. Company overview
- 7.3.2.2. Financial performance
- 7.3.2.3. Product benchmarking
- 7.3.2.4. Strategic initiatives
- 7.3.3. JEOL Ltd.
- 7.3.3.1. Company overview
- 7.3.3.2. Financial performance
- 7.3.3.3. Product benchmarking
- 7.3.3.4. Strategic initiatives
- 7.3.4. Klocke Nanotechnik GmbH
- 7.3.4.1. Company overview
- 7.3.4.2. Financial performance
- 7.3.4.3. Product benchmarking
- 7.3.4.4. Strategic initiatives
- 7.3.5. Kleindiek Nanotechnik GmbH
- 7.3.5.1. Company overview
- 7.3.5.2. Financial performance
- 7.3.5.3. Product benchmarking
- 7.3.5.4. Strategic initiatives
- 7.3.6. SmarAct GmbH
- 7.3.6.1. Company overview
- 7.3.6.2. Financial performance
- 7.3.6.3. Product benchmarking
- 7.3.6.4. Strategic initiatives
- 7.3.7. Nanonics Imaging Ltd.
- 7.3.7.1. Company overview
- 7.3.7.2. Financial performance
- 7.3.7.3. Product benchmarking
- 7.3.7.4. Strategic initiatives
- 7.3.8. Hummingbird Scientific
- 7.3.8.1. Company overview
- 7.3.8.2. Financial performance
- 7.3.8.3. Product benchmarking
- 7.3.8.4. Strategic initiatives
- 7.3.9. DNA Nanobots, LLC
- 7.3.9.1. Company overview
- 7.3.9.2. Financial performance
- 7.3.9.3. Product benchmarking
- 7.3.9.4. Strategic initiatives
- 7.3.10. Creative Biolabs
- 7.3.10.1. Company overview
- 7.3.10.2. Financial performance
- 7.3.10.3. Product benchmarking
- 7.3.10.4. Strategic initiatives
- 7.3.11. Theranautilus
- 7.3.11.1. Company overview
- 7.3.11.2. Financial performance
- 7.3.11.3. Product benchmarking
- 7.3.11.4. Strategic initiatives